Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

TTOO

T2 Biosystems (TTOO)

T2 Biosystems Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TTOO
DateHeureSourceTitreSymboleSociété
08/05/202401h46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TTOOT2 Biosystems Inc
07/05/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
07/05/202422h48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
07/05/202415h00GlobeNewswire Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseNASDAQ:TTOOT2 Biosystems Inc
06/05/202423h27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:TTOOT2 Biosystems Inc
06/05/202423h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTOOT2 Biosystems Inc
06/05/202422h34GlobeNewswire Inc.T2 Biosystems Announces First Quarter 2024 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
06/05/202422h34GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Middle East DistributorNASDAQ:TTOOT2 Biosystems Inc
06/05/202422h29GlobeNewswire Inc.T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
24/04/202415h00GlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
11/04/202422h05GlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
28/03/202414h00GlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
20/03/202412h30GlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
19/03/202414h00GlobeNewswire Inc.T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
18/03/202414h00GlobeNewswire Inc.T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance PanelNASDAQ:TTOOT2 Biosystems Inc
12/03/202414h00GlobeNewswire Inc.T2 Biosystems Receives Extension to Comply with Nasdaq Listing RequirementNASDAQ:TTOOT2 Biosystems Inc
04/03/202422h34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422h49Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422h06GlobeNewswire Inc.T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
15/02/202422h04GlobeNewswire Inc.T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
15/02/202422h02GlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and AsiaNASDAQ:TTOOT2 Biosystems Inc
14/02/202402h15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TTOOT2 Biosystems Inc
12/02/202415h00GlobeNewswire Inc.T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria PanelNASDAQ:TTOOT2 Biosystems Inc
07/02/202422h05GlobeNewswire Inc.T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024NASDAQ:TTOOT2 Biosystems Inc
18/01/202415h00GlobeNewswire Inc.T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia PatientsNASDAQ:TTOOT2 Biosystems Inc
03/01/202415h00GlobeNewswire Inc.T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric TestingNASDAQ:TTOOT2 Biosystems Inc
28/11/202322h00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTOOT2 Biosystems Inc
24/11/202322h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTOOT2 Biosystems Inc
03/11/202314h00GlobeNewswire Inc.T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:TTOOT2 Biosystems Inc
01/11/202314h00GlobeNewswire Inc.T2 Biosystems Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TTOOT2 Biosystems Inc
 Showing the most relevant articles for your search:NASDAQ:TTOO